Hims & Hers Health, Inc.
- HIMS · NYSE
- Services-Offices & Clinics of Doctors of Medicine
- San Francisco, CA
- 2,442 employees
- CIK 0001773751
Updated from SEC filings through
Top things to know
Revenue, FY2025$2.3B+59.0% vs FY2024Operating margin4.5%Operating income $106MEmployees2,442As of December 31, 2025Next earningsNovember 9, 202616:30 ETLatest 8-KDeparture or appointment of directors or officers; compensationFiled October 7, 2026Leadership changeItem 5.02 filedOctober 7, 2026, last 90 days
Executives
- Andrew Dudum Chief Executive Officer 4, 2026-08-27
- Oluyemi Okupe Chief Financial Officer 4, 2026-09-23
- Jonathan M. Franklin Chief Accounting Officer 3, 2026-10-15
- Michael Chi Chief Operating Officer 4, 2026-09-17
- Soleil Boughton Chief Legal Officer 4, 2026-09-17
- Deborah M. Autor Chief Policy Officer 4, 2026-08-20
What leadership is saying
“In healthcare, whoever owns the customer relationship wins, and that’s exactly what we’re building toward at Hims & Hers. Today, customers want real choice, real value, and a care team that knows them”
Earnings press release (8-K Ex. 99.1), filed November 9, 2026
Hims & Hers Health, Inc. is a U.S. public company in services-offices & clinics of doctors of medicine (SIC 8011), headquartered in San Francisco, CA. It trades as HIMS on NYSE. Revenue was $2.3B in the fiscal year ending December 31, 2025, +59.0% from the year before. It reported about 2,442 employees. Andrew Dudum is Chief Executive Officer.
Five-year financials
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.3B 10-K, 2026-02-23 | $1.5B 10-K, 2026-02-23 | $872M 10-K, 2026-02-23 | $527M 10-K, 2025-02-24 | $272M 10-K, 2024-02-26 |
| Operating income | $106M 10-K, 2026-02-23 | $61.9M 10-K, 2026-02-23 | -$29.5M 10-K, 2026-02-23 | -$68.7M 10-K, 2025-02-24 | -$115M 10-K, 2024-02-26 |
| SG&A | $273M 10-K, 2026-02-23 | $168M 10-K, 2026-02-23 | $130M 10-K, 2026-02-23 | $98.2M 10-K, 2025-02-24 | $184M 10-K, 2022-02-24 |
| Net income | $128M 10-K, 2026-02-23 | $126M 10-K, 2026-02-23 | -$23.5M 10-K, 2026-02-23 | -$65.7M 10-K, 2025-02-24 | -$108M 10-K, 2024-02-26 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Andrew Dudum | Chief Executive Officer | 4, 2026-08-27 |
| Oluyemi Okupe | Chief Financial Officer | 4, 2026-09-23 |
| Jonathan M. Franklin | Chief Accounting Officer | 3, 2026-10-15 |
| Michael Chi | Chief Operating Officer | 4, 2026-09-17 |
| Soleil Boughton | Chief Legal Officer | 4, 2026-09-17 |
| Deborah M. Autor | Chief Policy Officer | 4, 2026-08-20 |
| Patrick Harrison Carroll | Chief Medical Officer | 4, 2026-08-18 |
| Deb Autor | Board member (per proxy) bio: Chief Policy Officer and Director | DEF 14A, 2026-04-28 |
| Mohamed Elshenawy | CTO | 4, 2026-09-17 |
| Andrea Perez | Board member (per proxy) bio: Director | DEF 14A, 2026-04-28 |
| Anja Manuel | Board member (per proxy) bio: Director | DEF 14A, 2026-04-28 |
| Christopher Payne | Board member (per proxy) bio: Director | DEF 14A, 2026-04-28 |
| David Wells | Board member (per proxy) bio: Lead Independent Director | DEF 14A, 2026-04-28 |
| Delos Cosgrove, M.D. | Board member (per proxy) bio: Director | DEF 14A, 2026-04-28 |
| Kåre Schultz | Board member (per proxy) bio: Director | DEF 14A, 2026-04-28 |
| Kofi Amoo-Gottfried | Board member (per proxy) bio: Director Nominee | DEF 14A, 2026-04-28 |
What Hims & Hers Health, Inc. does
Launched in 2017, Hims & Hers Health, Inc. (and together with its subsidiaries, “Hims & Hers”, the “Company”, “we”, “us” or “our”) has built a consumer-first platform transforming the way customers fulfill their health and wellness needs. We believe that the Company has the technical infrastructure, distributed provider network, and access to clinical capabilities to lead the migration of routine office visits to a personalized, digital, accessible format.
Item 1. Business, 10-K for the year ending December 31, 2025
Shares and governance
| Public float | $10.1B (as of June 30, 2025) | 10-K, February 23, 2026 |
|---|---|---|
| Reportable segments | 1 (period ending September 30, 2026) | 10-Q, November 9, 2026 |
| Latest proxy statement | Meeting June 11, 2026 (filed April 28, 2026) | DEF 14A, April 28, 2026 |
| Auditor | Kpmg LLP (San Francisco, CA) | Latest 10-K |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| October 28, 2026 | Soleil Boughton Chief Legal Officer | Sale | 3,462 | $96K | Form 4, October 29, 2026 |
| October 14, 2026 | Soleil Boughton Chief Legal Officer | Sale | 3,461 | $101K | Form 4, October 15, 2026 |
| October 1, 2026 | Oluyemi Okupe Chief Financial Officer | Sale | 2,000 | $59K | Form 4, October 2, 2026 |
| September 30, 2026 | Soleil Boughton Chief Legal Officer | Sale | 3,461 | $101K | Form 4, October 2, 2026 |
| September 22, 2026 | Oluyemi Okupe Chief Financial Officer | Sale | 29,277 | $877K | Form 4, September 23, 2026 |
| September 17, 2026 | Oluyemi Okupe Chief Financial Officer | Sale | 12,313 | $355K | Form 4, September 18, 2026 |
| September 16, 2026 | Soleil Boughton Chief Legal Officer | Sale | 6,236 | $174K | Form 4, September 17, 2026 |
| September 15, 2026 | Mohamed Elshenawy CTO | Sale | 7,954 | $226K | Form 4, September 17, 2026 |
Recent 8-K events
- 8-K filed 2026-10-07
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2026-08-10
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-07-17
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2026-07-01
- Item 1.01 Entry into a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
- 8-K filed 2026-06-15
- Item 5.07 Submission of matters to a vote of security holders
- 8-K filed 2026-06-02
- Item 1.01 Entry into a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
- Item 8.01 Other events
- 8-K filed 2026-05-21
- Item 1.01 Entry into a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
- Item 3.02 Unregistered sales of equity securities
- 8-K filed 2026-05-19
- Item 8.01 Other events
- 8-K filed 2026-05-11
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-03-11
- Item 7.01 Regulation FD disclosure
Frequently asked questions about Hims & Hers Health, Inc.
- What does Hims & Hers Health, Inc. do?
- In its own words, from Item 1 of its 10-K: "Launched in 2017, Hims & Hers Health, Inc. (and together with its subsidiaries, “Hims & Hers”, the “Company”, “we”, “us” or “our”) has built a consumer-first platform transforming the way customers fulfill their health and wellness needs. We believe that the Company has the technical infrastructure, distributed provider network, and access to clinical capabilities to lead the migration of routine office visits to a personalized, digital, accessible format."
- What is Hims & Hers Health, Inc.'s revenue?
- $2.3B for the fiscal year ending December 31, 2025, from its 10-K filed February 23, 2026.
- Is Hims & Hers Health, Inc. profitable?
- Hims & Hers Health, Inc. reported net income of $128M for the fiscal year ending December 31, 2025.
- How many employees does Hims & Hers Health, Inc. have?
- About 2,442 as of December 31, 2025, as stated in its annual report.
- Who is the CEO of Hims & Hers Health, Inc.?
- Andrew Dudum, Chief Executive Officer, as named in a 4 filed August 27, 2026.
- Who is the CFO of Hims & Hers Health, Inc.?
- Oluyemi Okupe, Chief Financial Officer, as named in a 4 filed September 23, 2026.
- Where is Hims & Hers Health, Inc. headquartered?
- San Francisco, CA.
- What is Hims & Hers Health, Inc.'s stock ticker?
- HIMS on NYSE.
- What industry is Hims & Hers Health, Inc. in?
- Services-Offices & Clinics of Doctors of Medicine, SIC code 8011.
- What is Hims & Hers Health, Inc.'s website?
- hims.com.
- When does Hims & Hers Health, Inc. report earnings next?
- November 9, 2026 at 16:30. Source: pg_future_events.
- Is Hims & Hers Health, Inc. a public company?
- Yes. Hims & Hers Health, Inc. files with the SEC under CIK 0001773751 and trades as HIMS.
- Who audits Hims & Hers Health, Inc.?
- Kpmg LLP, San Francisco, CA, as named in its latest annual report (10-K).
- What is Hims & Hers Health, Inc.'s public float?
- $10.1B as of June 30, 2025, as reported on the cover of its 10-K filed February 23, 2026.
- How many business segments does Hims & Hers Health, Inc. report?
- 1 reportable segment for the period ending September 30, 2026, from its 10-Q filed November 9, 2026.
- When is Hims & Hers Health, Inc.'s annual shareholder meeting?
- June 11, 2026, per its proxy statement (DEF 14A) filed April 28, 2026.
- Have Hims & Hers Health, Inc. insiders traded stock recently?
- Since July 24, 2025, officers and directors reported 72 open-market sales worth about $110M and 1 purchase worth about $1.2M on Forms 4 and 5. The most recent: Soleil Boughton (Chief Legal Officer) sold 3,462 shares on October 28, 2026.